ReGen Biologics, Inc. (ReGen Biologics), a orthopedic devices company, has appointed Jay Flounlacker to the senior management team. He joins ReGen as the senior vice president (SVP), administration. He will be responsible for coordinating operations across the Company among other senior executives to optimize company resources to achieve training targets, sales and other goals.

His extensive healthcare background includes his most recent position as the vice president for service delivery at DST Health Solutions, where he led a team of over 200 employees in the US and India to provide implementation, consulting and technical support.

His experience also includes additional consulting and executive management positions at Epiphany Partners, Electronic Data Systems (EDS), First Consulting Group, APACHE Medical Systems, and Amisys Synertec.

Flounlacker previously worked with the ReGen management team on several consulting projects, and was involved with the Company’s successful 510(k) application for the Menaflex collagen meniscus implant.

“We are extremely pleased to have Jay on the team again, this time on a full-time basis,” said Gerald E. Bisbee, chairman and chief executive officer. “His expertise in project management and business process will be invaluable as we fully implement our Menaflex U.S. launch activities,” Bisbee continued.

Flounlacker holds an Executive MBA from Loyola College, and a BA in English from the University of Maryland, where he served on the College of Arts and Humanities Alumni board of directors.